Clinical Trials

Multiple Ascending Dose of BMS-911543

Location:

Rochester, MN

Trial status:

Open for Enrollment

Why is this study being done?

The purpose of this first in human study is to determine if BMS-911543 is safe and tolerable in subjects with symptomatic intermediate-1, intermediate-2 or high risk myelofibrosis to permit clinical testing at the Maximum Tolerated Dose or at a Clinically Active Dose, and to determine if BMS-911543 will demonstrate efficacy in symptomatic myelofibrosis.

Last updated: 06/18/2012

NCT ID:

NCT01236352